CJC-1295 NO DAC + IPAMORELIN

Description

Research focus: Growth-hormone signaling

A two-component blend associated with growth-hormone signaling research.

The menu lists 5 mg CJC-1295 NO DAC plus 5 mg ipamorelin. Ipamorelin has been studied for GH release; the exact identity of the NO DAC component and evidence for this mixture need confirmation.

Evidence context: Combination evidence not established

Read background source

Research findings describe the named compound, not verified results for a Peptix batch. For laboratory research use only. Not for human or animal consumption. Not for diagnostic or therapeutic use.